Foundation status offered to 38 more trusts
October 31, 2003A further 38 hospital have been invited to apply for foundation trust status after winning three stars in the recent …
Doubts over pipeline cloud Aventis results
October 31, 2003Aventis may struggle to replace revenue from its ageing blockbusters despite a strong performance in the second quarter, according to …
BMS and Lilly exceed expectations
October 31, 2003Strong sales of established and new products in the second quarter saw both Bristol-Myers Squibb and Eli Lilly beat analysts' …
Smooth transition from old to new for AstraZeneca
October 31, 2003Growth in new products are helping to plug the sizeable gap left by three of AstraZeneca's ageing blockbusters Prilosec (Losec), …
Weak dollar contains Sanofi growth
October 31, 2003The weakness of the US dollar more than halved Sanofi-Synthelabo's earnings in the first half of this year, but disguised …
Heart failure guidelines recommend ACE inhibitors
October 31, 2003ACE inhibitors have been recommended as first line treatment for chronic heart failure as part of a comprehensive set of …
Media training company launched
October 31, 2003A new training agency specialising in preparing pharmaceutical spokespeople to deal with modern media techniques has been launched.Asparagus Media, set …
Industry could gain access to yellow card data
October 31, 2003The pharmaceutical industry could be granted access to data from the UK's Yellow Card adverse effect warning system to assist …
Celebrex to gain orphan drug indication
October 31, 2003Pfizer's blockbuster arthritis drug Celebrex is set to gain a European orphan drug licence for the treatment of a rare …
Challenging second quarter for big pharma
October 31, 2003Generic competition and wholesaler de-stocking are among the problems besetting two of the industry's biggest hitters, GlaxoSmithKline and AstraZeneca.Deutsche Bank …
NHS leaders pour scorn on star ratings
October 31, 2003New star ratings for all NHS trusts have been attacked by leaders in primary and secondary care, who say they …
PCTs to hold balance of power in community pharmacy
October 31, 2003Pharmacy leaders have welcomed plans to protect local pharmacies from greater competition, but say crucial detail must now be agreed …
Breakthrough in consultant contract talks
October 31, 2003Doctors' leaders have declared a breakthrough in the long-running and bitter dispute over the new consultants' contract.The halving of the …
PR heavyweights launch new agency
October 29, 2003Former managing directors of Shire Health London and Cohn & Wolfe Healthcare have joined forces to launch a new independent, …
New R&D chief as Merck files Erbitux
October 29, 2003German pharmaceutical Merck KgaA has appointed a new head of clinical research and development following a major R&D re-organisation. Dr …
Liver test takes shine off Exanta
October 29, 2003AstraZeneca has admitted that patients on its new anti-clotting drug Exanta will need liver tests, denting the drug's profile as …
US approval for breakthrough diabetes device
October 29, 2003The first integrated glucose meter and insulin pump has been approved by the FDA, bringing the goal of an 'artificial …
Latest content
FibroFind appoints Lee Borthwick as CEO
